If you've noticed an error on the site, the information is inaccurate, or something is missing — let us know! Or maybe you'd like to suggest an idea — we'd love to hear it.

The European EUCanScreen initiative, in which Ukraine also takes part, has summed up the results of its first year of work. The project is aimed at developing and modernizing cancer screening programs across Europe and is being implemented under the EU4Health program and Europe's Beating Cancer Plan.
Screening means the early detection of cancer in people without symptoms. It is precisely this that makes it possible to find the disease at early stages, when treatment is most effective and less burdensome for the patient.
Project participants focused on:
Particular attention is being paid to approaches to screening that account for individual risk factors, as well as to reducing inequality in access to examinations.
Under wartime conditions, the burden on the healthcare system has grown significantly, and patients' access to preventive examinations has become more difficult. At the same time, it is precisely early detection of oncological diseases that reduces mortality and improves treatment effectiveness.
European initiatives are shaping modern screening standards, which Ukraine's healthcare system aims to integrate with. For the National Cancer Institute, this means:
Ukraine's integration into European oncology initiatives is an important step toward strengthening the early diagnosis system, improving the quality of medical care, and achieving better treatment outcomes for patients.

The 2026 class of interns has joined the Institute's team. Ahead of them lie clinical practice, mentorship from experienced specialists, and their first independent decisions.

A third high-precision radiation therapy unit will reduce waiting times and expand access to treatment for more patients.

The drug has been purchased with state budget funds for the first time. Who can join the program, which documents to prepare, and how to schedule a multidisciplinary board review.